Chemical formula: C₂₂H₁₈N₂ Molecular mass: 310.392 g/mol PubChem compound: 2378
Bifonazole is an imidazole derivative with a broad antimycotic spectrum, which includes dermatophytes, yeasts, moulds and other fungi such as Malassezia furfur. It is also effective against Corynebacterium minutissimum.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D01AC10 | Bifonazole | D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| CANESTEN BIFONAZOLE ONCE DAILY Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Bifonazole is an active ingredient of these brands:
Croatia (HR)Cyprus (CY)Finland (FI)France (FR)
Germany (DE)Hong Kong (HK)Ireland (IE)Israel (IL)
Japan (JP)Malta (MT)Mexico (MX)New Zealand (NZ)Poland (PL)
Singapore (SG)
South Africa (ZA)Spain (ES)
Turkey (TR)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
